Basal Cell Carcinoma (BCC) Active Not Recruiting Phase 2 Trials for Cotsiranib (DB18404)

Also known as: BCC - Basal Cell Carcinoma / Basal Cell Carcinomas / Basal Cell Carcinoma / Carcinoma basal cell / Basalioma / Basal cell epithelioma / Rodent ulcer / Basal cell carcinoma (morphologic abnormality) / Basal cell carcinoma of skin (disorder) / Carcinoma, Basal Cell

IndicationStatusPhase
DBCOND0040396 (Basal Cell Carcinoma (BCC))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs